Akeyna Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Investors
  • 8

Akeyna General Information

Description

Developer of medical devices designed to improve the lives of patients by minimizing risks associated with medical injections. The company's needle detects blood vessels to prevent severe complications such as blindness, which can occur when blood vessels are accidentally occluded with dermal fillers, enabling patients and physicians with improved medical technology.

Contact Information

Website
www.akeynamedical.com
Formerly Known As
3WMN Ventures
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 15 Teresa Circle
  • Arlington, MA 02474
  • United States
+1 (781)
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 15 Teresa Circle
  • Arlington, MA 02474
  • United States
+1 (781)

Akeyna Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akeyna Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Angel (individual) Completed Generating Revenue
5. Early Stage VC 24-Nov-2025 Completed Generating Revenue
4. Accelerator/Incubator 25-Jun-2025 Completed Generating Revenue
3. Accelerator/Incubator 29-May-2024 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Akeyna’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Akeyna Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Akeyna Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025229994-A1 Patient access system Pending 26-Feb-2024
WO-2025184141-A1 Patient access system Pending 26-Feb-2024

Akeyna Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cherrystone Angel Group Angel Group Minority
Launchpad Venture Group Angel Group Minority
Wire Group (Massachusetts) Angel Group Minority
Auxilium Worcester Accelerator/Incubator Minority
MedTech Innovator Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Akeyna FAQs

  • When was Akeyna founded?

    Akeyna was founded in 2022.

  • Where is Akeyna headquartered?

    Akeyna is headquartered in Arlington, MA.

  • What industry is Akeyna in?

    Akeyna’s primary industry is Surgical Devices.

  • Is Akeyna a private or public company?

    Akeyna is a Private company.

  • What is Akeyna’s current revenue?

    The current revenue for Akeyna is .

  • How much funding has Akeyna raised over time?

    Akeyna has raised $550K.

  • Who are Akeyna’s investors?

    Cherrystone Angel Group, Launchpad Venture Group, Wire Group (Massachusetts), Auxilium Worcester, and MedTech Innovator are 5 of 8 investors who have invested in Akeyna.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process